GPNMB and Alzheimer disease: In transgenic AD models, their immunohistochemistry, ELISA, and expression profiling tests found that GPNMB increases in an age-dependent manner and is co-localized with IBA1-positive microglia cells that cluster near amyloid plaques in the brain.